| Dr Sarah Beth Scott, MD | |
|
400 Highland Ave, Lewistown, PA 17044-1167 | |
| (717) 248-5411 | |
| Not Available |
| Full Name | Dr Sarah Beth Scott |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 400 Highland Ave, Lewistown, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225247760 | NPI | - | NPPES |
| Entity Name | Parkview Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2009 (3Q09) of $1.78, consistent with management's guidance of $1.75 to $1.80. The company earned $1.09 per share for the quarter ended September 30, 2008 (3Q08) which reflected $0.40 per share in realized losses primarily associated with other-than-temporary impairments in investments and sales of distressed financial institution securities.
Researchers have identified a potential marker of disease activity for a severe and often painful food allergic disease called eosinophilic esophagitis (EoE) - possibly sparing children with EoE the discomfort and risk of endoscopic procedures to assess whether their disease is active.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Scientists from King's College London and Imperial College London believe they have discovered a key element in the development of chronic asthma. Their research has been published in a new paper in the journal Proceedings of the National Academy of Sciences to explain why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.
› Verified 8 days ago
| Entity Name | Obhg Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811232218 PECOS PAC ID: 7315185691 Enrollment ID: O20130528000323 |
News Archive
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2009 (3Q09) of $1.78, consistent with management's guidance of $1.75 to $1.80. The company earned $1.09 per share for the quarter ended September 30, 2008 (3Q08) which reflected $0.40 per share in realized losses primarily associated with other-than-temporary impairments in investments and sales of distressed financial institution securities.
Researchers have identified a potential marker of disease activity for a severe and often painful food allergic disease called eosinophilic esophagitis (EoE) - possibly sparing children with EoE the discomfort and risk of endoscopic procedures to assess whether their disease is active.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Scientists from King's College London and Imperial College London believe they have discovered a key element in the development of chronic asthma. Their research has been published in a new paper in the journal Proceedings of the National Academy of Sciences to explain why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Beth Scott, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Sarah Beth Scott, MD 400 Highland Ave, Lewistown, PA 17044-1167 Ph: (717) 248-5411 |
News Archive
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2009 (3Q09) of $1.78, consistent with management's guidance of $1.75 to $1.80. The company earned $1.09 per share for the quarter ended September 30, 2008 (3Q08) which reflected $0.40 per share in realized losses primarily associated with other-than-temporary impairments in investments and sales of distressed financial institution securities.
Researchers have identified a potential marker of disease activity for a severe and often painful food allergic disease called eosinophilic esophagitis (EoE) - possibly sparing children with EoE the discomfort and risk of endoscopic procedures to assess whether their disease is active.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Scientists from King's College London and Imperial College London believe they have discovered a key element in the development of chronic asthma. Their research has been published in a new paper in the journal Proceedings of the National Academy of Sciences to explain why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.
› Verified 8 days ago
Marie C Smith, M.D, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 Highland Ave, Lewistown, PA 17044 Phone: 717-242-4200 Fax: 717-242-4212 | |
Dr. Olamide Kolade, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 Highland Ave, Lewistown, PA 17044 Phone: 717-248-5411 Fax: 717-242-4212 | |
Shashpal K Malhotra, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 18 N Main St, Lewistown, PA 17044 Phone: 717-242-1441 Fax: 701-242-6107 | |
Rajeshwar P Malhotra, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 18 N Main St, Lewistown, PA 17044 Phone: 717-242-1441 Fax: 717-242-6107 |